×

Sign In

Search
Home

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

By Thomson Reuters Mar 17, 2026 | 6:49 AM

March 17 (Reuters) – Pfizer said on Tuesday its experimental combination reduced the risk of disease progression or death by 40% in patients with breast cancer.

Here are some ‌details:

(Reporting by Sahil Pandey in Bengaluru; Editing by Krishna Chandra Eluri)

US weighs near $1 billion wind farm settlement for TotalEnergies, NYT reports

US National Counterterrorism Center director resigns over war in Iran

US home prices to crawl higher as 30-year mortgage rates stick near 6%: Reuters poll

GSR acquires crypto advisory firms in $57 million expansion

Wall St opens higher as investors weigh energy costs before Fed call

US lawmaker wants to collect EV fees for highway repairs

Privacy Policy
Terms Of Service

Copyright © 2026. All Rights Reserved.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at 715-842-1672.